Cargando…

Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro

Detalles Bibliográficos
Autores principales: Qin, Gaofeng, Dong, Yunfang, Liu, Zhenhong, Gong, Zhuoyan, Gao, Chenyan, Zheng, Mingcui, Tian, Meijing, He, Yannan, Zhong, Liqun, Wang, Pengwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719386/
https://www.ncbi.nlm.nih.gov/pubmed/34972523
http://dx.doi.org/10.1186/s13020-021-00551-x
_version_ 1784624926368464896
author Qin, Gaofeng
Dong, Yunfang
Liu, Zhenhong
Gong, Zhuoyan
Gao, Chenyan
Zheng, Mingcui
Tian, Meijing
He, Yannan
Zhong, Liqun
Wang, Pengwen
author_facet Qin, Gaofeng
Dong, Yunfang
Liu, Zhenhong
Gong, Zhuoyan
Gao, Chenyan
Zheng, Mingcui
Tian, Meijing
He, Yannan
Zhong, Liqun
Wang, Pengwen
author_sort Qin, Gaofeng
collection PubMed
description
format Online
Article
Text
id pubmed-8719386
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87193862022-01-05 Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro Qin, Gaofeng Dong, Yunfang Liu, Zhenhong Gong, Zhuoyan Gao, Chenyan Zheng, Mingcui Tian, Meijing He, Yannan Zhong, Liqun Wang, Pengwen Chin Med Correction BioMed Central 2021-12-31 /pmc/articles/PMC8719386/ /pubmed/34972523 http://dx.doi.org/10.1186/s13020-021-00551-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Qin, Gaofeng
Dong, Yunfang
Liu, Zhenhong
Gong, Zhuoyan
Gao, Chenyan
Zheng, Mingcui
Tian, Meijing
He, Yannan
Zhong, Liqun
Wang, Pengwen
Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro
title Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro
title_full Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro
title_fullStr Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro
title_full_unstemmed Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro
title_short Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro
title_sort correction to: shen-zhi-ling oral liquid ameliorates cerebral glucose metabolism disorder in early ad via insulin signal transduction pathway in vivo and in vitro
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719386/
https://www.ncbi.nlm.nih.gov/pubmed/34972523
http://dx.doi.org/10.1186/s13020-021-00551-x
work_keys_str_mv AT qingaofeng correctiontoshenzhilingoralliquidamelioratescerebralglucosemetabolismdisorderinearlyadviainsulinsignaltransductionpathwayinvivoandinvitro
AT dongyunfang correctiontoshenzhilingoralliquidamelioratescerebralglucosemetabolismdisorderinearlyadviainsulinsignaltransductionpathwayinvivoandinvitro
AT liuzhenhong correctiontoshenzhilingoralliquidamelioratescerebralglucosemetabolismdisorderinearlyadviainsulinsignaltransductionpathwayinvivoandinvitro
AT gongzhuoyan correctiontoshenzhilingoralliquidamelioratescerebralglucosemetabolismdisorderinearlyadviainsulinsignaltransductionpathwayinvivoandinvitro
AT gaochenyan correctiontoshenzhilingoralliquidamelioratescerebralglucosemetabolismdisorderinearlyadviainsulinsignaltransductionpathwayinvivoandinvitro
AT zhengmingcui correctiontoshenzhilingoralliquidamelioratescerebralglucosemetabolismdisorderinearlyadviainsulinsignaltransductionpathwayinvivoandinvitro
AT tianmeijing correctiontoshenzhilingoralliquidamelioratescerebralglucosemetabolismdisorderinearlyadviainsulinsignaltransductionpathwayinvivoandinvitro
AT heyannan correctiontoshenzhilingoralliquidamelioratescerebralglucosemetabolismdisorderinearlyadviainsulinsignaltransductionpathwayinvivoandinvitro
AT zhongliqun correctiontoshenzhilingoralliquidamelioratescerebralglucosemetabolismdisorderinearlyadviainsulinsignaltransductionpathwayinvivoandinvitro
AT wangpengwen correctiontoshenzhilingoralliquidamelioratescerebralglucosemetabolismdisorderinearlyadviainsulinsignaltransductionpathwayinvivoandinvitro